01477 歐康維視生物－Ｂ
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
18/08/2025Liu Ye1316(L)1,532,500(L)84,251,340(L)10.07
10/07/2025胡兆鹏1201(L)-3,715(L)4,246,478(L)0.51
10/07/2025胡兆鹏1711(L)15,000(L)4,250,193(L)0.51
04/07/2025Liu Ye1711(L)812,625(L)84,251,340(L)10.09
04/07/2025Morgan Stanley1704(L)-25,416,628(L)22,289,958(L)
6,016,022(S)
0(P)		2.67
0.72
0.00
03/07/2025Morgan Stanley1312(L)401,500(L)48,260,188(L)
6,579,022(S)
0(P)		5.78
0.78
0.00
02/07/2025Morgan Stanley1013(L)+38,205,670(L)48,260,188(L)
6,579,022(S)
0(P)		5.78
0.78
0.00
01/07/2025Suzhou Frontline BioVentures Venture Capital Fund II L.P. (蘇州通和二期創業投資合夥企業(有限合夥))1201(L)-25,900,000(L)62,440,000(L)7.47
01/07/2025Suzhou Yunchang Investment Consulting Co., Ltd. (蘇州蘊長投資諮詢有限公司)1201(L)-37,000,000(L)89,200,000(L)10.67
01/07/2025Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) (蘇州富沿創業投資管理合夥企業(有限合夥))1201(L)-25,900,000(L)62,440,000(L)7.47
01/07/2025張綺蘋1201(L)-37,000,000(L)89,200,000(L)10.67
24/06/2025Liu Ye1113(L)+8,138,350(L)84,251,340(L)10.09
24/06/2025胡兆鹏12041(L)-150,000(L)4,018,193(L)0.48
24/06/2025胡兆鹏1113(L)+232,000(L)4,250,193(L)0.51
13/06/2025胡兆鹏1201(L)-2,014(L)4,168,193(L)0.50
13/06/2025胡兆鹏1711(L)10,275(L)4,170,207(L)0.50
07/04/2025胡兆鹏1711(L)25,275(L)4,172,550(L)0.50
07/04/2025胡兆鹏1201(L)-2,343(L)4,170,207(L)0.50
07/04/2025Liu Ye1711(L)812,625(L)76,112,990(L)9.12
18/02/2025Liu Ye1316(L)647,000(L)76,112,990(L)9.12
20/01/2025Liu Ye1316(L)1,319,000(L)76,112,990(L)9.12
07/01/2025胡兆鹏1711(L)15,000(L)4,175,946(L)0.50
07/01/2025胡兆鹏1201(L)-3,396(L)4,172,550(L)0.50
06/01/2025Liu Ye1711(L)812,625(L)76,112,990(L)9.14
17/12/2024胡兆鹏1711(L)10,275(L)4,178,855(L)0.50
17/12/2024胡兆鹏1201(L)-2,909(L)4,175,946(L)0.60
18/10/2024Temasek Holdings (Private) Limited1201(L)-199,000(L)HKD 5.794(L)40,822,900(L)4.98
16/10/2024Suzhou Frontline BioVentures Venture Capital Fund II L.P. (蘇州通和二期創業投資合夥企業(有限合夥))1210(L)88,340,000(L)88,340,000(L)10.78
16/10/2024Alcon Inc.1002(L)+139,159,664(L)139,159,664(L)16.71
16/10/2024Alcon Pharmaceuticals Ltd1002(L)+139,159,664(L)139,159,664(L)16.71
16/10/2024Suzhou Yunchang Investment Consulting Co., Ltd. (蘇州蘊長投資諮詢有限公司)1210(L)126,200,000(L)126,200,000(L)15.40
16/10/2024Suzhou 6Dimensions Venture Capital Partnership L.P. (蘇州通和毓承投資合夥企業(有限合夥))1210(L)37,860,000(L)37,860,000(L)4.62
16/10/20246 Dimensions Capital, L.P.1210(L)119,890,000(L)119,890,000(L)14.63
16/10/2024Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) (蘇州富沿創業投資管理合夥企業(有限合夥))1210(L)88,340,000(L)88,340,000(L)10.78
16/10/2024Suzhou Tongyu Investment Management Partnership (Limited Partnership) (蘇州通毓投資管理合夥企業(有限合夥))1210(L)37,860,000(L)37,860,000(L)4.62
16/10/20246 Dimensions Capital GP, LLC1210(L)126,200,000(L)126,200,000(L)15.40
16/10/2024Summer Iris Limited1213(L)78,214,230(L)9.39
16/10/2024Temasek Holdings (Private) Limited1213(L)41,104,400(L)5.01
16/10/2024Boyu Capital Fund IV, L.P.1213(L)78,214,230(L)9.39
16/10/2024Boyu Capital General Partner IV, Ltd1213(L)78,214,230(L)9.39
 1    2  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.